The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy

被引:7
作者
Chen, Fanglu [1 ,2 ,3 ]
Xue, Yucheng [1 ,2 ,3 ]
Zhang, Wenkan [1 ,2 ,3 ]
Zhou, Hao [1 ,2 ,3 ]
Zhou, Zhiyi [4 ]
Chen, Tao [1 ,2 ,3 ]
Eloy, Yinwang [1 ,2 ,3 ]
Li, Hengyuan [1 ,2 ,3 ]
Ye, Zhaoming [1 ,2 ,3 ]
Gao, Junjie [5 ]
Wang, Shengdong [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Musculoskeletal Tumor Ctr, Dept Orthoped,Sch Med, Hangzhou 310009, Peoples R China
[2] Zhejiang Univ, Inst Orthoped Res, Hangzhou 310009, Peoples R China
[3] Key Lab Motor Syst Dis Res & Precis Therapy Zhejia, Hangzhou, Zhejiang, Peoples R China
[4] First Peoples Hosp Yuhang Dist, Hangzhou, Zhejiang, Peoples R China
[5] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed, Sch Med, Shanghai 200233, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor metastasis; Metabolism; Mitophagy; Mitochondrial genetics; Mitochondria transfer; Immunotherapy; DNA COPY NUMBER; HEPATOCELLULAR-CARCINOMA METASTASIS; IMMUNOGENIC CELL-DEATH; RANDOMIZED PHASE-II; GLUCOSE-METABOLISM; TUNNELING NANOTUBES; ANTITUMOR-ACTIVITY; PANCREATIC-CANCER; MICROSATELLITE INSTABILITY; MESENCHYMAL TRANSITION;
D O I
10.1007/s10555-024-10211-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mitochondria are central actors in diverse physiological phenomena ranging from energy metabolism to stress signaling and immune modulation. Accumulating scientific evidence points to the critical involvement of specific mitochondrial-associated events, including mitochondrial quality control, intercellular mitochondrial transfer, and mitochondrial genetics, in potentiating the metastatic cascade of neoplastic cells. Furthermore, numerous recent studies have consistently emphasized the highly significant role mitochondria play in coordinating the regulation of tumor-infiltrating immune cells and immunotherapeutic interventions. This review provides a comprehensive and rigorous scholarly investigation of this subject matter, exploring the intricate mechanisms by which mitochondria contribute to tumor metastasis and examining the progress of mitochondria-targeted cancer therapies.
引用
收藏
页码:1419 / 1443
页数:25
相关论文
共 316 条
[1]   Movement of Mitochondria with Mutant DNA through Extracellular Vesicles Helps Cancer Cells Acquire Chemoresistance [J].
Abad, Etna ;
Lyakhovich, Alex .
CHEMMEDCHEM, 2022, 17 (04)
[2]   Targeting dormant cancer [J].
Aguirre-Ghiso, Julio A. ;
Bragado, Paloma ;
Sosa, Maria Soledad .
NATURE MEDICINE, 2013, 19 (03) :276-277
[3]   Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy [J].
Ahmad, Tanveer ;
Mukherjee, Shravani ;
Pattnaik, Bijay ;
Kumar, Manish ;
Singh, Suchita ;
Kumar, Manish ;
Rehman, Rakhshinda ;
Tiwari, Brijendra K. ;
Jha, Kumar A. ;
Barhanpurkar, Amruta P. ;
Wani, Mohan R. ;
Roy, Soumya S. ;
Mabalirajan, Ulaganathan ;
Ghosh, Balaram ;
Agrawal, Anurag .
EMBO JOURNAL, 2014, 33 (09) :994-1010
[4]   The Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation [J].
Alberghina, Lilia .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)
[5]   Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial [J].
Alistar, Angela ;
Morris, Bonny B. ;
Desnoyer, Rodwige ;
Klepin, Heidi D. ;
Hosseinzadeh, Keyanoosh ;
Clark, Clancy ;
Cameron, Amy ;
Leyendecker, John ;
D'Agostino, Ralph, Jr. ;
Topaloglu, Umit ;
Boteju, Lakmal W. ;
Boteju, Asela R. ;
Shorr, Rob ;
Zachar, Zuzana ;
Bingham, Paul M. ;
Ahmed, Tamjeed ;
Crane, Sandrine ;
Shah, Riddhishkumar ;
Migliano, John J. ;
Pardee, Timothy S. ;
Miller, Lance ;
Hawkins, Gregory ;
Jin, Guangxu ;
Zhang, Wei ;
Pasche, Boris .
LANCET ONCOLOGY, 2017, 18 (06) :770-778
[6]   Miro1-mediated mitochondrial positioning supports subcellular redox status [J].
Alshaabi, Haya ;
Shannon, Nathaniel ;
Gravelle, Randi ;
Milczarek, Stephanie ;
Messier, Terri ;
Cunniff, Brian .
REDOX BIOLOGY, 2021, 38
[7]   Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium [J].
Alva, Ajjai ;
Slovin, Susan ;
Daignault, Stephanie ;
Carducci, Michael ;
DiPaola, Robert ;
Pienta, Ken ;
Agus, David ;
Cooney, Kathleen ;
Chen, Alice ;
Smith, David C. ;
Hussain, Maha .
INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) :749-757
[8]  
Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12
[9]   Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments [J].
Angelin, Alessia ;
Gil-de-Gomez, Luis ;
Dahiya, Satinder ;
Jiao, Jing ;
Guo, Lili ;
Levine, Matthew H. ;
Wang, Zhonglin ;
Quinn, William J., III ;
Kopinski, Piotr K. ;
Wang, Liqing ;
Akimova, Tatiana ;
Liu, Yujie ;
Bhatti, Tricia R. ;
Han, Rongxiang ;
Laskin, Benjamin L. ;
Baur, Joseph A. ;
Blair, Ian A. ;
Wallace, Douglas C. ;
Hancock, Wayne W. ;
Beier, Ulf H. .
CELL METABOLISM, 2017, 25 (06) :1282-+
[10]   Mitochondria in Health and Disease [J].
Annesley, Sarah J. ;
Fisher, Paul R. .
CELLS, 2019, 8 (07)